The Robotic Innovation Summit (RIS) at Meril Academy in Vapi, Gujarat, marked a significant step in India's adoption of surgical robotics. The event gathered esteemed surgeons from around the globe to discuss advancements in robotic-assisted surgery, particularly focusing on Meril's AI-powered joint replacement system, Misso. This technology is enhancing surgical precision and improving patient outcomes across the country.
Misso, launched in June 2024, has already seen over 50 installations in India, showcasing its rapid integration into healthcare. The summit also highlighted Meril's ongoing research and development projects aimed at expanding robotic solutions for complex surgical needs. Meril's commitment to making advanced surgical technologies accessible throughout India reflects its vision for a collaborative healthcare ecosystem.
• Misso's AI capabilities enhance surgical precision and patient recovery times.
• Meril aims to make robotic surgery accessible across India.
AI-powered systems like Misso utilize advanced algorithms for real-time analytics in surgery.
Robotic-assisted surgery involves using robotic systems to enhance surgical procedures and outcomes.
Real-time analytics in Misso provide surgeons with immediate data to improve decision-making during operations.
Meril is a leading medical device manufacturer in India, focusing on innovative surgical technologies like Misso.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.